tirzepatide fda shortage update backtracks over Eli Lilly weight-loss drug Important Notice: Tirzepatide Compounding Update

Wegovy This brand name for semaglutide is approved for weight loss

Therefore, you should avoid misuse like excessive dosing, poor-quality products, or unverified treatments

Contraindications Do Not Use If You Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Have had a serious hypersensitivity reaction to semaglutide or any component of the formulation Are pregnant, planning to become pregnant, or breastfeeding Warnings and Precautions Pancreatitis: Acute and chronic pancreatitis have been reported

Novos US patent for semaglutide expires 2031 and as early in 2026 in China and Canada

Its peptide vs GLP-1 in action: a natural stimulation of your bodys own fat-burning hormones versus an external hormone (like semaglutide) that alters appetite